Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.

Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS; MESEMS study group.

Trials. 2019 May 9;20(1):263. doi: 10.1186/s13063-019-3346-z.

2.

Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype.

Grangeon L, Wallon D, Charbonnier C, Quenez O, Richard AC, Rousseau S, Budowski C, Lebouvier T, Corbille AG, Vidailhet M, Méneret A, Roze E, Anheim M, Tranchant C, Favrole P, Antoine JC, Defebvre L, Ayrignac X, Labauge P, Pariente J, Clanet M, Maltête D, Rovelet-Lecrux A, Boland A, Deleuze JF; French PFBC study group , Frebourg T, Hannequin D, Campion D, Nicolas G.

Brain. 2019 Jun 1;142(6):1573-1586. doi: 10.1093/brain/awz095.

PMID:
31009047
3.

Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.

Vukusic S, Casey R, Rollot F, Brochet B, Pelletier J, Laplaud DA, De Sèze J, Cotton F, Moreau T, Stankoff B, Fontaine B, Guillemin F, Debouverie M, Clanet M; the OFSEP Investigators.

Mult Scler. 2018 Dec 13:1352458518815602. doi: 10.1177/1352458518815602. [Epub ahead of print]

PMID:
30541380
4.

Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab.

Durrieu G, Dardonville Q, Clanet M, Montastruc JL.

Fundam Clin Pharmacol. 2019 Feb;33(1):125-126. doi: 10.1111/fcp.12394. Epub 2018 Jul 12.

PMID:
29935014
5.

Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorder.

Biotti D, Lerebours F, Bonneville F, Ciron J, Clanet M, Brassat D.

Mult Scler. 2018 Oct;24(12):1645-1647. doi: 10.1177/1352458518765677. Epub 2018 May 9.

PMID:
29741120
6.

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20.

PMID:
29353550
7.

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Erratum in: Eur J Neurol. 2018 Mar;25(3):605.

PMID:
29352526
8.

[Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders].

Krolak-Salmon P, Letrilliart L, Ceccaldi M, Andrieu S, Guérin O, Dubois B, Brochet B, Vandel P, Jeandel C, Leperre-Desplanques A, Clanet M, Druais PL.

Presse Med. 2018 Jan;47(1):75-83. doi: 10.1016/j.lpm.2017.10.029. Epub 2017 Dec 26. French.

PMID:
29287728
9.

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.

Pivot D, Debouverie M, Grzebyk M, Brassat D, Clanet M, Clavelou P, Confavreux C, Edan G, Leray E, Moreau T, Vukusic S, Hédelin G, Guillemin F.

PLoS One. 2016 Dec 9;11(12):e0167556. doi: 10.1371/journal.pone.0167556. eCollection 2016.

10.

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.

Papeix C, Vukusic S, Casey R, Debard N, Stankoff B, Mrejen S, Uhry Z, Van Ganse E, Castot A, Clanet M, Lubetzki C, Confavreux C; TYSEDMUS and OFSEP Group.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e297. eCollection 2016 Dec.

11.

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.

Tourbah A, Lebrun-Frenay C, Edan G, Clanet M, Papeix C, Vukusic S, De Sèze J, Debouverie M, Gout O, Clavelou P, Defer G, Laplaud DA, Moreau T, Labauge P, Brochet B, Sedel F, Pelletier J; MS-SPI study group.

Mult Scler. 2016 Nov;22(13):1719-1731. Epub 2016 Sep 1.

12.

Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.

Castel-Lacanal E, Gamé X, Clanet M, De Boissezon X, Brassat D, Rischmann P, Marque P.

Neurourol Urodyn. 2017 Mar;36(3):706-709. doi: 10.1002/nau.23002. Epub 2016 Mar 29.

PMID:
27028504
13.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Leray E, Vukusic S, Debouverie M, Clanet M, Brochet B, de Sèze J, Zéphir H, Defer G, Lebrun-Frenay C, Moreau T, Clavelou P, Pelletier J, Berger E, Cabre P, Camdessanché JP, Kalson-Ray S, Confavreux C, Edan G.

PLoS One. 2015 Jul 6;10(7):e0132033. doi: 10.1371/journal.pone.0132033. eCollection 2015.

14.

Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesion.

Pique J, Bonneville F, Brassat D, Peaureaux D, Benaiteau M, Dumas H, Fabre N, Clanet M, Biotti D.

Mult Scler. 2015 Jul;21(8):1080-3. doi: 10.1177/1352458515586087. Epub 2015 May 26.

PMID:
26014609
15.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

PMID:
25527826
16.

Fingolimod treatment after natalizumab-related progressive multifocal leukoencephalopathy: three new cases.

Peaureaux D, Pignolet B, Biotti D, Bucciarelli F, Gaina J, Bucur C, Clanet M, Martin-Blondel G, Brassat D.

Mult Scler. 2015 Apr;21(5):671-2. doi: 10.1177/1352458514549823. Epub 2014 Oct 10. No abstract available.

PMID:
25305251
17.

A central nervous system B-cell lymphoma arising two years after initial diagnosis of CLIPPERS.

Taieb G, Uro-Coste E, Clanet M, Lassmann H, Benouaich-Amiel A, Laurent C, Delisle MB, Labauge P, Brassat D.

J Neurol Sci. 2014 Sep 15;344(1-2):224-6. doi: 10.1016/j.jns.2014.06.015. Epub 2014 Jun 18. No abstract available.

PMID:
24990651
18.

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH.

Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28.

19.

[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].

Lionnet C, Carra C, Ayrignac X, Levade T, Gayraud D, Castelnovo G, Besson G, Androdias G, Vukusic S, Confavreux C, Zaenker C, De Seze J, Collongues N, Blanc F, Tranchant C, Wallon D, Hannequin D, Gerdelat-Mas A, Brassat D, Clanet M, Zephir H, Outteryck O, Vermersch P, Labauge P.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):445-53. doi: 10.1016/j.neurol.2014.01.675. Epub 2014 Apr 16. French.

PMID:
24746394
20.

[Implementation of a massive transfusion protocol in an emergency department].

Tonglet M, Minon JM, Damas F, Clanet M, Vergnion M.

Rev Med Liege. 2014 Feb;69(2):82-8. French.

21.

Risk evaluation and monitoring in multiple sclerosis therapeutics.

Clanet MC, Wolinsky JS, Ashton RJ, Hartung HP, Reingold SC.

Mult Scler. 2014 Sep;20(10):1306-11. doi: 10.1177/1352458513513207. Epub 2013 Nov 30. Review.

22.

Christian Confavreux (1949 - 2013).

Weinshenker BG, Vukusic S, Clanet MG.

Mult Scler. 2013 Dec;19(14):1811-2. doi: 10.1177/1352458513512239. No abstract available.

PMID:
24277730
23.

Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.

Castel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, Bourg V, Viala F, Rischmann P, Marque P.

Neurourol Urodyn. 2015 Jan;34(1):32-6. doi: 10.1002/nau.22495. Epub 2013 Sep 23.

PMID:
24115110
24.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
25.

Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.

Castel-Lacanal E, Gamé X, De Boissezon X, Guillotreau J, Braley-Berthoumieux E, Terracol C, Gasq D, Labrunee M, Viala F, Rischmann P, Clanet M, Marque P.

World J Urol. 2013 Dec;31(6):1445-50. doi: 10.1007/s00345-012-1017-8. Epub 2013 Jan 6.

PMID:
23292297
26.

A case report of simultaneous PML-IRIS during corticosteroids tapering in a patient with an anti-synthetase syndrome.

Martin-Blondel G, Brassat D, Dumas H, Uro-Coste E, Adoue D, Lassmann H, Clanet M.

F1000Res. 2013 Dec 23;2:283. doi: 10.12688/f1000research.2-283.v1. eCollection 2013.

27.

Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.

Nicolas G, Pottier C, Maltête D, Coutant S, Rovelet-Lecrux A, Legallic S, Rousseau S, Vaschalde Y, Guyant-Maréchal L, Augustin J, Martinaud O, Defebvre L, Krystkowiak P, Pariente J, Clanet M, Labauge P, Ayrignac X, Lefaucheur R, Le Ber I, Frébourg T, Hannequin D, Campion D.

Neurology. 2013 Jan 8;80(2):181-7. doi: 10.1212/WNL.0b013e31827ccf34. Epub 2012 Dec 19.

PMID:
23255827
28.

Initial experience of single-port surgery assisted by percutaneous instruments for gastric bypass: a combination of safety and minimally invasive surgery.

Kotzampassakis N, Machairas N, Clanet M, Cornet P, Dandrifosse AC.

Obes Surg. 2013 Feb;23(2):267-71. doi: 10.1007/s11695-012-0793-y.

PMID:
23224508
29.

[Foreword].

Clanet M.

Rev Neurol (Paris). 2012 Nov;168(11):795. doi: 10.1016/j.neurol.2012.10.006. French. No abstract available.

PMID:
23153832
30.

Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.

Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P, Fedirko E, Lejeune E, Cottineau J, Brusco A, Dollfus H, Chinnery PF, Mancini C, Ferrer X, Sole G, Destée A, Mayer JM, Fontaine B, de Seze J, Clanet M, Ollagnon E, Busson P, Cazeneuve C, Stevanin G, Kaplan J, Rozet JM, Brice A, Durr A.

Brain. 2012 Oct;135(Pt 10):2980-93. doi: 10.1093/brain/aws240.

31.

Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis.

Guillotreau J, Panicker JN, Castel-Lacanal E, Viala F, Roumiguié M, Malavaud B, Marque P, Clanet M, Rischmann P, Gamé X.

Urology. 2012 Oct;80(4):852-7. doi: 10.1016/j.urology.2012.06.039. Epub 2012 Aug 29.

PMID:
22939550
32.

Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients.

Taieb G, Duflos C, Renard D, Audoin B, Kaphan E, Pelletier J, Limousin N, Tranchant C, Kremer S, de Sèze J, Lefaucheur R, Maltête D, Brassat D, Clanet M, Desbordes P, Thouvenot E, Magy L, Vincent T, Faillie JL, de Champfleur N, Castelnovo G, Eimer S, Branger DF, Uro-Coste E, Labauge P.

Arch Neurol. 2012 Jul;69(7):847-55. doi: 10.1001/archneurol.2012.122.

PMID:
22777259
33.

Increased risk of multiple sclerosis relapse after in vitro fertilisation.

Michel L, Foucher Y, Vukusic S, Confavreux C, de Sèze J, Brassat D, Clanet M, Clavelou P, Ouallet JC, Brochet B, Pelletier J, Labauge P, Lebrun C, Lepage E, Le Frere F, Jacq-Foucher M, Barriere P, Wiertlewski S, Laplaud DA; Club Francophone de la Sclérose En Plaques (CFSEP).

J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):796-802. doi: 10.1136/jnnp-2012-302235. Epub 2012 Jun 11.

PMID:
22693287
34.

[Address from the previous president, January 13, 2012].

Clanet M.

Rev Neurol (Paris). 2012 Mar;168(3):205-6. doi: 10.1016/j.neurol.2012.02.005. French. No abstract available.

PMID:
22449587
35.

Unexpected entropy response to saline spraying at the end of posterior fossa surgery: a few cases report.

Clanet M, Bonhomme V, Lhoest L, Born JD, Hans P.

Acta Anaesthesiol Belg. 2011;62(2):87-90.

PMID:
21919375
36.

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.

Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radü EW, Sørensen PS, King J.

Lancet Neurol. 2011 Aug;10(8):745-58. doi: 10.1016/S1474-4422(11)70149-1. Review.

PMID:
21777829
37.

[Pseudoxanthoma elasticum and obstetric epidural analgesia: report of a case].

Clanet M, Chantraine F, Dewandre PY, Peeters P, Foidart JM, Brichant JF.

Ann Fr Anesth Reanim. 2011 Sep;30(9):685-7. doi: 10.1016/j.annfar.2011.05.008. Epub 2011 Jun 25. French.

38.

[Address from the president, January 14, 2011].

Clanet M.

Rev Neurol (Paris). 2011 Mar;167(3):191-3. doi: 10.1016/j.neurol.2011.02.033. French. No abstract available.

PMID:
21420537
39.

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS.

Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.

40.

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.

Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu-Rebeix I, Goertsches RH, Zettl UK, Comabella M, Montalban X, Rieckmann P, Weber F, Müller-Myhsok B, Edan G, Fontaine B, Mars LT, Saoudi A, Oksenberg JR, Clanet M, Liblau RS, Brassat D.

Brain. 2011 Mar;134(Pt 3):693-703. doi: 10.1093/brain/awr010.

PMID:
21354972
41.

Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.

Rudick RA, Kappos L, Kinkel R, Clanet M, Phillips JT, Herndon RM, Sandrock AW, Munschauer FE 3rd.

Mult Scler. 2011 Mar;17(3):353-60. doi: 10.1177/1352458510384605. Epub 2010 Oct 21.

PMID:
20965959
42.

EFNS guidelines on diagnosis and management of neuromyelitis optica.

Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B.

Eur J Neurol. 2010 Aug;17(8):1019-32. doi: 10.1111/j.1468-1331.2010.03066.x. Epub 2010 Jun 7. Review.

PMID:
20528913
43.

A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.

Jagodic M, Colacios C, Nohra R, Dejean AS, Beyeen AD, Khademi M, Casemayou A, Lamouroux L, Duthoit C, Papapietro O, Sjöholm L, Bernard I, Lagrange D, Dahlman I, Lundmark F, Oturai AB, Soendergaard HB, Kemppinen A, Saarela J, Tienari PJ, Harbo HF, Spurkland A, Ramagopalan SV, Sadovnick DA, Ebers GC, Seddighzadeh M, Klareskog L, Alfredsson L, Padyukov L, Hillert J, Clanet M, Edan G, Fontaine B, Fournié GJ, Kockum I, Saoudi A, Olsson T.

Sci Transl Med. 2009 Dec 9;1(10):10ra21. doi: 10.1126/scitranslmed.3000278.

44.

Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma.

Benouaich-Amiel A, Lubrano V, Tafani M, Uro-coste E, Gantet P, Sol JC, Roux F, Bousquet P, Julian A, Sabatier J, Tremoulet M, Cances-Lauwers V, Delisle MB, Clanet M, Esquerré JP, Payoux P.

Arch Neurol. 2010 Mar;67(3):370-2. doi: 10.1001/archneurol.2010.22.

PMID:
20212242
45.

Neuromyelitis optica in France: a multicenter study of 125 patients.

Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C, de Seze J.

Neurology. 2010 Mar 2;74(9):736-42. doi: 10.1212/WNL.0b013e3181d31e35.

PMID:
20194912
46.

[Multiple sclerosis in Haute-Garonne: an important underestimation of case numbers].

Sagnes-Raffy C, Gourraud PA, Hannon V, Bourrel R, Laffontan MA, Gaulene MC, Viala F, Clanet M.

Rev Epidemiol Sante Publique. 2010 Feb;58(1):23-31. doi: 10.1016/j.respe.2009.08.012. Epub 2010 Jan 27. French.

PMID:
20106619
47.

MS Forum Workshop: looking ahead: advances in multiple sclerosis in the next decade.

Clanet M, Ebers GC.

Int MS J. 2009 Jun;16(2):67-70. No abstract available.

PMID:
19671370
48.

Multiple dural lesions mimicking meningiomas in patients with CCM3/PDCD10 mutations.

Labauge P, Fontaine B, Neau JP, Bergametti F, Riant F, Blecon A, Marchelli F, Arnoult M, Lannuzel A, Clanet M, Olschwang S, Denier C, Tournier-Lasserve E.

Neurology. 2009 Jun 9;72(23):2044-6. doi: 10.1212/WNL.0b013e3181a92b13. No abstract available.

PMID:
19506228
50.

IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.

Couturier N, Gourraud PA, Cournu-Rebeix I, Gout C, Bucciarelli F, Edan G, Babron MC, Clerget-Darpoux F, Clanet M, Fontaine B, Brassat D.

Eur J Hum Genet. 2009 Jun;17(6):844-7. doi: 10.1038/ejhg.2008.259. Epub 2009 Jan 21.

Supplemental Content

Loading ...
Support Center